These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31319783)
1. Predicting outcomes in patients with cancer and atrial fibrillation. Gutierrez A; Patell R; Rybicki L; Khorana AA Ther Adv Cardiovasc Dis; 2019; 13():1753944719860676. PubMed ID: 31319783 [TBL] [Abstract][Full Text] [Related]
2. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
3. The Value of the CHADS Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of CHADS2 and CHA2DS2-VASc Scores for Stroke Prediction in Patients With Cancer and Atrial Fibrillation. Patell R; Gutierrez A; Rybicki L; Khorana AA Am J Cardiol; 2017 Dec; 120(12):2182-2186. PubMed ID: 29033049 [TBL] [Abstract][Full Text] [Related]
5. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation. Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940 [TBL] [Abstract][Full Text] [Related]
6. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219 [TBL] [Abstract][Full Text] [Related]
7. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
8. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy. Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957 [TBL] [Abstract][Full Text] [Related]
9. CHADS Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462 [TBL] [Abstract][Full Text] [Related]
10. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113 [TBL] [Abstract][Full Text] [Related]
11. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation. Zhu WG; Xiong QM; Hong K Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792 [TBL] [Abstract][Full Text] [Related]
13. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation. Tokunaga K; Yamagami H; Koga M; Todo K; Kimura K; Itabashi R; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Kario K; Yagita Y; Kitazono T; Kinoshita N; Takasugi J; Okata T; Yoshimura S; Sato S; Arihiro S; Toyoda K; Cerebrovasc Dis; 2018; 45(3-4):170-179. PubMed ID: 29597211 [TBL] [Abstract][Full Text] [Related]
14. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [TBL] [Abstract][Full Text] [Related]
15. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126 [TBL] [Abstract][Full Text] [Related]
16. Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study. Nielsen PB; Overvad TF; Andersen SD; Larsen TB; Skjøth F; Søgaard M; Lip GYH Cerebrovasc Dis; 2019; 48(3-6):236-243. PubMed ID: 31846970 [TBL] [Abstract][Full Text] [Related]
17. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
18. Pre-Admission CHADS2 and CHA2DS2-VASc Scores on Early Neurological Worsening. Nam KW; Kim CK; Yu S; Chung JW; Bang OY; Kim GM; Jung JM; Song TJ; Kim YJ; Kim BJ; Heo SH; Park KY; Kim JM; Park JH; Choi JC; Park MS; Kim JT; Choi KH; Hwang YH; Oh K; Seo WK Cerebrovasc Dis; 2021; 50(3):288-295. PubMed ID: 33588410 [TBL] [Abstract][Full Text] [Related]
19. Comparison of CHA Hu WS; Lin CL Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]